NBE Therapeutics
SwitzerlandEntry
2013
Hold
7yr
Exit
2020
Who owns NBE Therapeutics?
NBE Therapeutics is a Swiss Biotech company, now owned by Boehringer Ingelheim, which acquired it in 2020 from Boehringer Ingelheim Venture Fund.
Hand-verified · updated 2026-07-07
Open JSON · CC-BY
Exit Type
Trade Sale
Buyer
Boehringer Ingelheim
Exit Year
2020
More from Boehringer Ingelheim Venture Fund
Other portfolio companies in the same fund.
Germany
US
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns NBE Therapeutics?
NBE Therapeutics is now owned by Boehringer Ingelheim, which acquired it in 2020 from Boehringer Ingelheim Venture Fund.
When did Boehringer Ingelheim acquire NBE Therapeutics?
Boehringer Ingelheim acquired NBE Therapeutics in 2020, buying from Boehringer Ingelheim Venture Fund.
Who did NBE Therapeutics sell to?
Boehringer Ingelheim Venture Fund sold NBE Therapeutics to Boehringer Ingelheim in 2020 (Trade Sale).
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue